Company

MDx Health

Epigenetics is an exciting area of molecular biology that identifies key changes in gene activity that do not involve changes to the underlying genetic code. Epigenetic “markers” tell genes to switch on or off, to speak loudly or whisper. It is through these epigenetic markers that environmental factors like diet, stress and prenatal nutrition can make an imprint on genes (DNA methylation) that are passed from one generation to the next. Some of these DNA methylation imprints can turn a healthy cell into a cancer cell.

We believe that our proprietary, accurate and scalable epigenetic-based as well as RNA-based technologies provide a key competitive advantage in the diagnosis, prognosis and management of cancer. In addition to our ongoing and planned studies for our tests to assess the risk of aggressive prostate cancer (SelectMDx and ConfirmMDx) and bladder cancer (AssureMDx), our product pipeline includes also tests for kidney cancer and other urological cancers.

MDxHealth’s US headquarters are located in Irvine, California. The European Headquarters recently moved to the Novio Tech Campus in Nijmegen. Here we have completed build-out and certification (ISO 13485-2016) of our state-of-the-art laboratory facilities, significantly expanding our capacity and infrastructure to perform our commercial tests and clinical studies, as well as ongoing research and development.

MDxHealth

Transistorweg 5 (building M)

6534 AT Nijmegen

The Netherlands

+31 (0) 88 32 72 727

info@mdxhealth.com

Website

More companies in this area

DFE Pharma

DFE Pharma develops, produces and supplies excipients for use in oral solid dose and dry powder inhalation,

Vaxxinova

Vaxxinova develops, produces and markets a wide range of innovative vaccines and diagnostic services to protect livestock and fish against diseases.

TropIQ

TropIQ Health Sciences offers laboratory screening services for the discovery and development of drugs against malaria.

Protinhi Therapeutics

Protinhi Therapeutics is an early stage biotech company, developing novel drugs against diseases with a high unmet medical need using proprietary technology and compounds that target diseases via Protease Inhibition. The focus of Protinhi is on upcoming viral threats and particularly on Dengue and Zika.

Okklo Life Sciences

Okklo Life Sciences is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies, with a focus on neglected and orphan diseases.

Avivia

Avivia is an independent specialized pharmaceutical development company engaged in drug repositioning, repurposing and reformulation.

Settle at Novio Tech Campus!

Connect with Novio Tech Campus!